BoNT/B Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BoNT/B monoclonal antibodies for research focused on understanding the biological functions and mechanisms of Botulinum Neurotoxin type B. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Botulinum Neurotoxin type B is a potent neurotoxin produced by the bacterium Clostridium botulinum, which inhibits neurotransmitter release, leading to muscle paralysis. Understanding BoNT/B function is crucial for developing therapeutic strategies for conditions such as dystonia and spasticity, as well as for advancing research in neurobiology. Research on BoNT/B provides valuable insights into synaptic transmission and the mechanisms of neurotoxicity. Investigating BoNT/B has led to significant discoveries in neuromuscular junction biology and potential therapeutic applications. Current research continues to uncover new aspects of BoNT/B's role in cellular signaling pathways and neurological disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of BoNT/B's role in neurological function and disease treatment.